ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $71,869,000 | +82.7% | 773,286 | +17.1% | 0.02% | +69.2% |
Q3 2021 | $39,331,000 | -27.3% | 660,447 | -16.8% | 0.01% | -23.5% |
Q2 2021 | $54,122,000 | +6.5% | 793,526 | +8.3% | 0.02% | 0.0% |
Q1 2021 | $50,830,000 | +0.6% | 732,583 | +11.4% | 0.02% | -5.6% |
Q4 2020 | $50,504,000 | -4.9% | 657,324 | -7.4% | 0.02% | -21.7% |
Q3 2020 | $53,100,000 | +18.6% | 709,957 | -0.2% | 0.02% | +15.0% |
Q2 2020 | $44,774,000 | +66.4% | 711,284 | +11.0% | 0.02% | +42.9% |
Q1 2020 | $26,911,000 | -8.9% | 640,765 | -1.5% | 0.01% | +27.3% |
Q4 2019 | $29,538,000 | -13.4% | 650,325 | -12.7% | 0.01% | -15.4% |
Q3 2019 | $34,115,000 | -1.4% | 745,358 | +26.4% | 0.01% | 0.0% |
Q2 2019 | $34,585,000 | +52.4% | 589,906 | +16.6% | 0.01% | +44.4% |
Q1 2019 | $22,689,000 | +9.8% | 506,129 | -4.6% | 0.01% | 0.0% |
Q4 2018 | $20,663,000 | +24.9% | 530,482 | +47.5% | 0.01% | +50.0% |
Q3 2018 | $16,542,000 | – | 359,528 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |